Cellino (@cellinobio) 's Twitter Profile
Cellino

@cellinobio

Building an ultra-scalable biomanufacturing technology stack for personalized cell and tissue replacement therapies.

ID: 938800346683592704

linkhttp://www.cellinobio.com calendar_today07-12-2017 16:00:19

778 Tweet

1,1K Followers

318 Following

Cellino (@cellinobio) 's Twitter Profile Photo

🚀 Exciting news! Cellino’s iPSC manufacturing technology has received the U.S. FDA Advanced Manufacturing Technology (AMT) designation, recognizing the potential to enhance scalability & quality in personalized #regenmed! Learn more: businesswire.com/news/home/2025…

🚀 Exciting news! Cellino’s iPSC manufacturing technology has received the <a href="/US_FDA/">U.S. FDA</a> Advanced Manufacturing Technology (AMT) designation, recognizing the potential to enhance scalability &amp; quality in personalized #regenmed! 
Learn more: businesswire.com/news/home/2025…
Cellino (@cellinobio) 's Twitter Profile Photo

Check out the latest blog from our Co-Founder & Chief Product Officer Marinna Madrid, who led the strategy that secured the U.S. FDA Advanced Manufacturing Technology designation—recognizing Cellino's innovation in #regenmed manufacturing. 📖 Read it here: linkedin.com/pulse/from-inv…

Check out the latest blog from our Co-Founder &amp; Chief Product Officer <a href="/MadridMarinna/">Marinna Madrid</a>, who led the strategy that secured the <a href="/US_FDA/">U.S. FDA</a> Advanced Manufacturing Technology designation—recognizing Cellino's innovation in #regenmed manufacturing. 
📖 Read it here: linkedin.com/pulse/from-inv…
Cellino (@cellinobio) 's Twitter Profile Photo

Regulatory recognition invites reflection—not just on the science, but on the journey behind it. In this video, Marinna Madrid shares her path as a founder and regulatory leader, and what the FDA’s AMT designation means for the future of #regenmed. 🎥⬇️ vimeo.com/1088041888?sha…

Cellino (@cellinobio) 's Twitter Profile Photo

We're excited to introduce Ethan Goldman as a Mechanical Engineer at Cellino! After 3 years interning with us in #automation and #mechanicalengineering, his experience will support our efforts to advance #biomanufacturing for personalized medicine. Welcome aboard, Ethan! 🚀

We're excited to introduce Ethan Goldman as a Mechanical Engineer at <a href="/CellinoBio/">Cellino</a>! After 3 years interning with us in #automation and #mechanicalengineering, his experience will support our efforts to advance #biomanufacturing for personalized medicine. Welcome aboard, Ethan! 🚀
Cellino (@cellinobio) 's Twitter Profile Photo

🧬 Join us at the ARM & Cell and Gene Therapy Catapult Workshop in #StevenageUK! @MarinnaMadrid, Co-Founder & CPO of Cellino, will present on "Scaling Regenerative Medicines to Meet Global Need,” and speak on a panel discussing #AI/#ML in #biomanufacturing on June 13. 👉

🧬 Join us at the ARM &amp; Cell and Gene Therapy Catapult Workshop in #StevenageUK! @MarinnaMadrid, Co-Founder &amp; CPO of <a href="/CellinoBio/">Cellino</a>, will present on "Scaling Regenerative Medicines to Meet Global Need,” and speak on a panel discussing #AI/#ML in #biomanufacturing on June 13.

👉
Cellino (@cellinobio) 's Twitter Profile Photo

🚀 If you’re in #Boston next week for #BIO2025, we’re looking forward to seeing you there! Join our Co-Founders, CEO Nabiha Saklayen and Chief Product Officer @MarinnaMadrid, as they speak on early-stage #investment, advanced #biomanufacturing, and expanding #healthequity.

Cellino (@cellinobio) 's Twitter Profile Photo

Big news! Our CEO Nabiha Saklayen has been named an Entrepreneur Of The Year 2025 New England Award Winner by EY US! 🎉 Her bold vision is shaping the future of regenerative medicine. Read more: businesswire.com/news/home/2025… #EOY25 #Cellino #RegenerativeMedicine

Cellino (@cellinobio) 's Twitter Profile Photo

It’s been an exhilarating week in #Boston at #BIO25! We’re honored to have our Co-Founders, CEO Nabiha Saklayen and Chief Product Officer Marinna Madrid, share how we’re accelerating the development of personalized #regenmed and building toward a future of #healthequity. Thank you to

It’s been an exhilarating week in #Boston at #BIO25! We’re honored to have our Co-Founders, CEO <a href="/nabsicle/">Nabiha Saklayen</a>  and Chief Product Officer <a href="/MadridMarinna/">Marinna Madrid</a>, share how we’re accelerating the development of personalized #regenmed and building toward a future of #healthequity. Thank you to
Cellino (@cellinobio) 's Twitter Profile Photo

📢 Excited to share Willie Reaves, our Head of Public Engagement, is a keynote speaker at AI for Good 🇺🇳 #AIforGood in #Geneva on July 9! Join us for his session on #AI-driven #biomanufacturing & the future of personalized #regenmed. #AIforGood 🔗See details: aiforgood.itu.int/summit-2025

📢 Excited to share <a href="/TheWillieT/">Willie Reaves</a>, our Head of Public Engagement, is a keynote speaker at <a href="/AIforGood/">AI for Good 🇺🇳 #AIforGood</a> in #Geneva on July 9! Join us for his session on #AI-driven #biomanufacturing &amp; the future of personalized #regenmed. #AIforGood

đź”—See details: aiforgood.itu.int/summit-2025
Cellino (@cellinobio) 's Twitter Profile Photo

🔬 We’re honored to join leaders from across the #regenerativemedicine community at @AllianceRM’s 2025 Cell & Gene Congressional Fly-In, where Marinna Madrid, will represent Cellino from July 22–23 on #CapitolHill. 🔗 bit.ly/3TV5223

🔬 We’re honored to join leaders from across the #regenerativemedicine community at @AllianceRM’s  2025 Cell &amp; Gene Congressional Fly-In, where <a href="/MadridMarinna/">Marinna Madrid</a>, will represent <a href="/CellinoBio/">Cellino</a> from July 22–23 on #CapitolHill. 🔗 bit.ly/3TV5223
Cellino (@cellinobio) 's Twitter Profile Photo

🚀Join us in #Japan for Keio University’s 8th Regeneration & Drug Discovery Seminar on Aug 4! Marinna Madrid will speak on “Autonomous Biomanufacturing of #iPSC-Based Cell Therapies” and share our vision for a more scalable future in #healthcare. 📧 Questions or RSVP requests:

🚀Join us in #Japan for <a href="/Keio_Univ/">Keio University</a>’s 8th Regeneration &amp; Drug Discovery Seminar on Aug 4! <a href="/MadridMarinna/">Marinna Madrid</a> will speak on “Autonomous Biomanufacturing of #iPSC-Based Cell Therapies” and share our vision for a more scalable future in #healthcare.

đź“§ Questions or RSVP requests:
Cellino (@cellinobio) 's Twitter Profile Photo

📢 Marinna Madrid will speak at @cira_ku_e’s Seminar Series on August 8 from 4:00 to 5:00 PM JST at Kyoto_News! She’ll present Nebula, our #AI-driven platform for scalable production of #iPSC-derived therapies. đź“§ Register: [email protected]

📢 <a href="/MadridMarinna/">Marinna Madrid</a> will speak at @cira_ku_e’s Seminar Series on August 8 from 4:00 to 5:00 PM JST at Kyoto_News! She’ll present Nebula, our #AI-driven platform for scalable production of #iPSC-derived therapies.

đź“§ Register: research_support_g@cira.kyoto-u.ac.jp
Cellino (@cellinobio) 's Twitter Profile Photo

🗓 Join us Aug 12 at The Engine in #Cambridge for Cellino's seminar with Dr. Hideyuki Okano on the world’s first clinical trial using #iPSC-derived therapy for #spinalcordinjury. Learn, ask questions, & network with #Boston’s innovation leaders! 👉 Register now:

🗓 Join us Aug 12 at The Engine in #Cambridge for <a href="/CellinoBio/">Cellino</a>'s seminar with Dr. Hideyuki Okano on the world’s first clinical trial using #iPSC-derived therapy for #spinalcordinjury. Learn, ask questions, &amp; network with #Boston’s innovation leaders!

👉 Register now:
Cellino (@cellinobio) 's Twitter Profile Photo

🚨 Tomorrow at The Engine in #Cambridge: Join Cellino & Dr. Hideyuki Okano for breakthrough #iPSC spinal cord injury trial results + Q&A & networking. See you 12:30–2:30 PM EDT! 👉 Limited seats! Register now: bit.ly/45ES3Z8

🚨 Tomorrow at The Engine in #Cambridge: Join <a href="/CellinoBio/">Cellino</a> &amp; Dr. Hideyuki Okano for breakthrough #iPSC spinal cord injury trial results + Q&amp;A &amp; networking. See you 12:30–2:30 PM EDT!

👉 Limited seats! Register now: bit.ly/45ES3Z8
Cellino (@cellinobio) 's Twitter Profile Photo

🧬How can #AI scale autologous iPSC therapies? Bar Makovoz, PhD, our Associate Director of Product Management, shares insights Oct 9 at ISSCR’s AI & Digital Biology Symposium in #Seattle. Join us: bit.ly/3HJLPhq

🧬How can #AI scale autologous iPSC therapies? Bar Makovoz, PhD, our Associate Director of Product Management, shares insights Oct 9 at <a href="/ISSCR/">ISSCR</a>’s  AI &amp; Digital Biology Symposium in #Seattle. 

Join us: bit.ly/3HJLPhq
Cellino (@cellinobio) 's Twitter Profile Photo

📢 Honored to announce that our Co-Founder & CEO, Nabiha Saklayen, will be co-chairing the NASEM Health’s “Developing Regenerative Medicine Therapies with #AI” workshop on Nov 18 in #DC. 👉 Join us in person or online: bit.ly/4n2GP6s

📢 Honored to announce that our Co-Founder &amp; CEO, <a href="/nabsicle/">Nabiha Saklayen</a>, will be co-chairing the <a href="/NASEM_Health/">NASEM Health</a>’s “Developing Regenerative Medicine Therapies with #AI” workshop on Nov 18 in #DC. 

👉 Join us in person or online: bit.ly/4n2GP6s
Cellino (@cellinobio) 's Twitter Profile Photo

Think of your body as the greatest artwork ever created. Each cell is a brushstroke. Today our Co-Founder & CPO Marinna Madrid is launching her Substack, starting with how iPSCs let us rewind biology’s brushstrokes!🎨 Take a peek → substack.com/@biophysica/p-…

Think of your body as the greatest artwork ever created. Each cell is a brushstroke.
Today our Co-Founder &amp; CPO <a href="/MadridMarinna/">Marinna Madrid</a> is launching her Substack, starting with how iPSCs let us rewind biology’s brushstrokes!🎨
Take a peek → substack.com/@biophysica/p-…
Cellino (@cellinobio) 's Twitter Profile Photo

👏 Congratulations to our Founder & CEO, Nabiha Saklayen named a 2025 @BioSpace 40 Under 40 honoree for #innovation and #patientimpact in #biotech! See the full list ➡️ bit.ly/4o5FegH

👏 Congratulations to our Founder &amp; CEO, <a href="/nabsicle/">Nabiha Saklayen</a> named a 2025 @BioSpace 40 Under 40 honoree for #innovation and #patientimpact in #biotech!

See the full list ➡️ bit.ly/4o5FegH